Zobrazeno 1 - 10
of 281
pro vyhledávání: '"Seiki Hasegawa"'
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-7 (2024)
Abstract Objective Our previous study revealed that the viscosity of fibrinogen could influence the effectiveness of ventilation and anchoring (V/A) methods for controlling air leakages. Here, we examined the association between the viscosity of fibr
Externí odkaz:
https://doaj.org/article/2b38c6d5c70243cc837898c76b0ac1ad
Autor:
Kentaro Miura, Kimihiro Shimizu, Seiki Hasegawa, Sachie Koike, Shunichiro Matsuoka, Tetsu Takeda, Takashi Eguchi, Kazutoshi Hamanaka, Momoko Takizawa
Publikováno v:
Thoracic Cancer, Vol 13, Iss 1, Pp 126-128 (2022)
Abstract A 70‐year‐old man diagnosed with right‐sided malignant epithelial pleural mesothelioma, underwent pleurectomy/decortication after three courses of neoadjuvant chemotherapy. He had a history of mitral valve replacement and maze procedur
Externí odkaz:
https://doaj.org/article/6e7af95dc31e4a98b6f02a8b856b38a7
Autor:
Kazuhiro Kitajima, Tatsuya Tsuchitani, Yoshiyuki Takahashi, Toshiyuki Minami, Takashi Yokoi, Akifumi Nakamura, Masaki Hashimoto, Kozo Kuribayashi, Takashi Kijima, Seiki Hasegawa, Koichiro Yamakado
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 391-396 (2021)
We report a case of bone metastasis arising from lung cancer, including quantitative values obtained with bone single-photon emission computed tomography/computed tomography (SPECT/CT), which were useful to evaluate the treatment response. The first
Externí odkaz:
https://doaj.org/article/252fd836fe8f4a2dbd977a2bdeb983ae
Autor:
Nobuyuki Kondo, Yoshitaka Takegawa, Masaki Hashimoto, Seiji Matsumoto, Shiro Oka, Seiki Hasegawa
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 15, Iss 1, Pp 1-5 (2020)
Abstract Background The present study aimed to use an ex-vivo model to investigate whether a new method involving the use of fibrin glue and a polyglycolic acid (PGA) sheet under ventilation enhances the sealing effect after repair of the pleural def
Externí odkaz:
https://doaj.org/article/66faf5be06ef4bff8a0406f75d23e7fe
Autor:
Takashi Tanaka BSc, Shinichiro Morishita PhD, Masaki Hashimoto PhD, MD, Toru Nakamichi MD, Yuki Uchiyama PhD, MD, Seiki Hasegawa PhD, MD, Kazuhisa Domen PhD, MD
Publikováno v:
Integrative Cancer Therapies, Vol 20 (2021)
Purpose: Health utility, which is a measure of patient-reported outcome (PRO), has recently been used in health-related quality of life for patients with various cancers. However, the relationship between health utility and the physical function and
Externí odkaz:
https://doaj.org/article/a7ab98ac9714473aa62549f6b034dfb1
Autor:
Masaki Hashimoto, Michiko Yuki, Kazuhiro Kitajima, Akihiro Fukuda, Toru Nakamichi, Akifumi Nakamura, Ayumi Kuroda, Seiji Matsumoto, Nobuyuki Kondo, Ayuko Sato, Koichiro Yamakado, Tohru Tsujimura, Seiki Hasegawa
Publikováno v:
Cancers, Vol 14, Iss 18, p 4356 (2022)
To investigate the incidence and risk factors of chest wall metastasis (CWM) at biopsy sites in patients with malignant pleural mesothelioma (MPM). This retrospective cohort study was conducted in 262 consecutive MPM patients who underwent multimodal
Externí odkaz:
https://doaj.org/article/3e21a396a07b41cfbb5d9acf3378f7f4
Autor:
Masaki Hashimoto, Yoshitomo Okumura, Fumihiro Tanaka, Kazue Yoneda, Teruhisa Takuwa, Nobuyuki Kondo, Seiki Hasegawa
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 1, Pp 169-174 (2017)
Tumor resection with cardiopulmonary bypass (CPB) remains controversial in the field of oncology. Here, we present a 57-year-old male patient with locally advanced squamous cell carcinoma. The tumor was located in the left hilum and invaded the left
Externí odkaz:
https://doaj.org/article/a69df35f73d545b3a155abccbae36f21
Autor:
Kazuhiro Kitajima, Mitsunari Maruyama, Hiroyuki Yokoyama, Toshiyuki Minami, Takashi Yokoi, Akifumi Nakamura, Masaki Hashimoto, Nobuyuki Kondo, Kozo Kuribayashi, Takashi Kijima, Seiki Hasegawa, Koichiro Yamakado
Publikováno v:
Cancers, Vol 13, Iss 5, p 1098 (2021)
Background: To compare three FDG-PET criteria (EORTC, PERCIST, imPERCIST) with CT criteria (combined modified RECIST and RECIST 1.1) for response evaluation and prognosis prediction in patients with recurrent MPM treated with ICI monotherapy. Methods
Externí odkaz:
https://doaj.org/article/7302a8a352c447d1a9f88168302cf505
Autor:
Hisao Asamura, Katherine K. Nishimura, Dorothy J. Giroux, Kari Chansky, Antje Hoering, Valerie Rusch, Ramón Rami-Porta, Luiz Henrique Araujo, David Beer, Pietro Bertoglio, Ricardo Beyruti, Andrea Billè, Souheil Boubia, Elisabeth Brambilla, A.K. Cangir, David Carbone, Vanessa Cilento, Casey Connolly, Gail Darling, Frank Detterbeck, Daniel Dibaba, Xavier Benoit D’Journo, Jessica Donington, Wilfried Eberhardt, John Edwards, Jeremy Erasmus, Wentao Fang, Dean Fennell, Kwun Fong, Françoise Galateau-Sallé, Oliver Gautschi, Ritu R. Gill, Dorothy Giroux, Meredith Giuliani, Jin Mo Goo, Seiki Hasegawa, Fred Hirsch, Hans Hoffman, Wayne Hofstetter, James Huang, Philippe Joubert, Kemp Kernstine, Keith Kerr, Young Tae Kim, Dong Kwan Kim, Hedy Kindler, Yolande Lievens, Hui Liu, Donald E. Low, Gustavo Lyons, Heber MacMahon, Alyson Mahar, Mirella Marino, Edith M. Marom, José-María Matilla, Jan van Meerbeeck, Luis M. Montuenga, Andrew Nicholson, Katie Nishimura, Anna Nowak, Isabelle Opitz, Meinoshin Okumura, Raymond U. Osarogiagbon, Harvey Pass, Marc de Perrot, Helmut Prosch, David Rice, Andreas Rimner, Adam Rosenthal, Enrico Ruffini, Shuji Sakai, Paul Van Schil, Navneet Singh, Francisco Suárez, Ricardo M. Terra, William D. Travis, Ming S. Tsao, Paula Ugalde, Shun-ichi Watanabe, Ignacio Wistuba, Murry Wynes, Yasushi Yatabe
Publikováno v:
Journal of Thoracic Oncology. 18:564-575
Autor:
Akifumi Nakamura, Masaki Hashimoto, Nobuyuki Kondo, Seiji Matsumoto, Ayumi Kuroda, Toshiyuki Minami, Kazuhiro Kitajima, Kozo Kuribayashi, Takashi Kijima, Seiki Hasegawa
Publikováno v:
International Journal of Clinical Oncology. 28:409-415
Treatment of recurrent malignant pleural mesothelioma (MPM) remains challenging. Our study examined the efficacy, tolerability, and safety of nivolumab with ipilimumab treatment for recurrent MPM after primary curative-intent surgery.Treatment compri